Evidence does not support Trump’s paracetamol claims: FIP


International pharmacy organisation backs paracetamol as “first-choice painkiller for pregnant women”, in response to White House warnings  Misinformation about the safety of medications poses a risk to patient trust in treatments, the International Pharmaceutical Federation (FIP) says.  In a statement FIP raised concerns about claims made by US President, Donald Trump, linking paracetamol use during pregnancy

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Raids aim to disrupt illicit vape distribution
Next Second eczema treatment pulled from PBS listing